Dublin, Dec. 18, 2017 -- The "Lower Urinary Tract Symptoms Forecast in 12 Major Markets 2018-2028" report has been added to Research and Markets' offering.
This report provides the current prevalent population for Lower Urinary Tract Symptoms across 12 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Russia, Japan, China, India, Brazil) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Lower urinary tract symptoms (LUTS) are a standardised group of symptoms related to problems with the voiding, storage and post-micturition of urine, occurring in both males and females. Differences between sexes regarding the type and frequency of symptoms have been observed. LUTS are a major burden for middle-aged and elderly people, and have a significant influence on health-related quality of life in that group.
Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Lower Urinary Tract Symptoms have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main co-morbidities for Crohn's disease include:
- Overweight and obesity
- Arterial hypertension
- Diabetes mellitus
- Coronary artery disease
- Metabolic syndrome (obesity, hypertension, diabetes and dyslipidaemia)
- Urinary tract infections
- Neurological disorders
- Erectile dysfunction in men
Key Topics Covered:
- Introduction
- Cause of the Disease
- Risk Factors & Prevention
- Diagnosis of the Disease
- Variation by Geography/Ethnicity
- Disease Prognosis & Clinical Course
- Key Comorbid Conditions / Features Associated With the Disease
- Methodology for Quantification of Patient Numbers
- Additional Data Available on Request
- Top-Line Prevalence for Lower Urinary Tract Symptoms
- Features of Lower Urinary Tract Symptoms Patients
- Male Patients With Lower Urinary Tract Symptoms
- Female Patients With Lower Urinary Tract Symptoms
- Comorbid Conditions of Luts Patients
- Abbreviations Used in the Report
- Other Publications
- Online Patient-Based Databases
- Patient-Based Offering
- Online Pricing Data & Platforms
- References
- Appendix
For more information about this report visit https://www.researchandmarkets.com/research/r78bmt/global_lower?w=12
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Urological Disorders Drugs


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Anta Sports Expands Global Footprint With Strategic Puma Stake
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 



